Study guide
11.1 Sequential UF, Hemofiltration and Hemoperfusion
BONENT Certified Hemodialysis Nurse CHN
Track your progress as you read
Finished sections get a check mark.
1 Exam Orientation
1.1 Current CHN Exam Facts and Study Strategy
2 Chapter 1: Renal Anatomy, Physiology & CKD Pathophysiology
2.1 Nephron Physiology & Endocrine Functions 2.2 Acute Kidney Injury & Chronic Kidney Disease Staging 2.3 Fluid, Electrolyte & Acid-Base Imbalances in ESRD
3 Chapter 2: CKD-MBD, Uremia & Clinical Manifestations
3.1 CKD-Mineral and Bone Disorder (CKD-MBD) 3.2 Uremic Syndrome & Multi-System Complications 3.3 Dialysis Patient Education & Nutritional Management
4 Individualized Nursing Care
4.1 Nursing Assessment, Planning and Evaluation 4.2 Treatment Records and Safe Handoffs 4.3 Psychosocial Assessment, Counseling and Referral
5 Chapter 3: Principles of Hemodialysis & Dialysate Chemistry
5.1 Transport Mechanisms: Diffusion, Convection & Ultrafiltration 5.2 Dialyzer Characteristics, Membrane Biocompatibility & Flux 5.3 Dialysate Composition & Concentrate Formulations 5.4 Hemodialysis Adequacy: Urea Kinetics, Kt/V & URR
6 Chapter 4: Vascular Access: Fistulas, Grafts & Catheters
6.1 Arteriovenous Fistulas & Arteriovenous Grafts 6.2 Physical Examination, Surveillance & Monitoring of Access 6.3 Central Venous Catheters & CDC Infection Prevention
7 Chapter 5: Cannulation Practice & Access Complications
7.1 Cannulation Techniques: Rope-Ladder, Buttonhole & Needle Sizing 7.2 Vascular Access Stenosis, Thrombosis & Steal Syndrome 7.3 Access Infiltration, Pseudoaneurysms & Hemorrhage Management
8 Chapter 6: Hemodialysis Treatment Delivery & Circuit Monitoring
8.1 Pre-Dialysis Assessment, Target Dry Weight & UFR Limits 8.2 Extracorporeal Circuit Setup, Priming & Safety Alarms 8.3 Anticoagulation Management: Heparin Protocols & Citrate 8.4 Treatment Termination, Hemostasis & Post-Dialysis Assessment
9 Equipment and Laboratory Skills
9.1 Ancillary Equipment and Bedside Safety 9.2 Blood Sampling, Laboratory Trends and Critical Results
10 Chapter 7: Acute Intradialytic Complications & Emergencies
10.1 Intradialytic Hypotension & Muscle Cramping 10.2 Dialysis Disequilibrium Syndrome & Neurological Events 10.3 Dialyzer Reactions & Hypersensitivity (Type A and Type B) 10.4 Critical Emergencies: Air Embolism, Hemolysis & Blood Loss
11 Extended and Acute Treatment
11.1 Sequential UF, Hemofiltration and Hemoperfusion 11.2 Acute Kidney Injury and High-Risk Dialysis Initiation
12 Chapter 8: Nephrology Pharmacology in Hemodialysis
12.1 Anemia Management: ESAs & Intravenous Iron Therapy 12.2 CKD-MBD Pharmacotherapy: Binders, Vitamin D & Calcimimetics 12.3 Cardiovascular, Antimicrobial & Dialyzable Drug Dosing
13 Home and Peritoneal Dialysis
13.1 Home Dialysis Selection and Adult Learning 13.2 Home Setup, Monitoring and Emergency Readiness 13.3 Peritoneal Dialysis Principles and Nursing Care
14 Kidney Transplantation
14.1 Transplant Benefits, Burdens and Modality Counseling 14.2 Transplant Indications, Contraindications and Referral 14.3 Pretransplant Workup and Waiting-List Coordination 14.4 Immunosuppressants, Interactions and Patient Teaching 14.5 Returning to Dialysis After Graft Failure 14.6 New-Graft Monitoring and Urgent Changes
15 Chapter 9: Water Treatment Systems & Dialyzer Reprocessing
15.1 AAMI/ISO Water Treatment Architecture & Components 15.2 Chemical Contaminant Monitoring & Total Chlorine Testing 15.3 Microbiological Standards, Endotoxin Surveillance & Sampling 15.4 Dialyzer Reprocessing Standards, Testing & Germicide Safety
16 Clinical Unit Management
16.1 Evaluating Dialysis Technology and Supplies 16.2 Staffing, Personnel Policies and Standards of Care
17 Chapter 10: Supervision, Administration & Professional Practice
17.1 RN Delegation, Technician Supervision & Nurse Practice Acts 17.2 CMS Conditions for Coverage & Interdisciplinary Care Planning 17.3 Dialysis Unit Infection Control & Environmental Safety 17.4 Quality Improvement (ESRD QIP), Ethics & Palliative Care
18 Professional Development
18.1 Professional Literature, Organizations and Continuing Learning 18.2 Research Design, Implementation and Evidence Interpretation 18.3 Staff Training, Competency and Remediation
19 Environmental Hazards and Emergency Planning
19.1 Chemical Agents, Disinfection and Exposure Control 19.2 Biological Hazards and Occupational Injury Response 19.3 Fire, Threats and Power or Water Interruptions
11.1 Sequential UF, Hemofiltration and Hemoperfusion
Key Takeaways Explain This Topic AI
Isolated UF removes water without providing ordinary diffusive clearance.
Hemofiltration uses convection and replacement fluid; hemodiafiltration adds diffusion.
Hemoperfusion adsorbs selected substances and requires agent-specific specialist planning.
Last updated: October 2026
Match the Method to the Problem
BONENT's outline explicitly includes sequential ultrafiltration, hemoperfusion, hemofiltration, bicarbonate dialysis and high-sodium techniques. These are not interchangeable versions of ordinary HD. The nurse must understand the dominant transport process, the clinical purpose and the added monitoring requirements. A method that improves volume control may not provide adequate solute removal, and a method useful for one toxin may be ineffective for another.
Isolated ultrafiltration removes plasma water under pressure without the usual dialysate-mediated diffusion. Small solutes move with the removed water, but the net clearance is limited by the removed volume. It is primarily a volume-removal strategy. Sequential treatment may deliver an isolated-UF phase followed or preceded by a diffusive phase. The order identifies the sequence, duration, fluid goal and monitoring. Do not count an hour of isolated UF as an hour of ordinary urea clearance.
Sequential UF and Hemodynamic Tolerance
During conventional HD, both osmotic change and volume removal affect vascular stability. Separating them can help selected patients, but isolated UF can still cause hypotension if removal exceeds plasma refill. It is not an automatically gentle or risk-free alternative. Assess symptoms, pressure, access and cumulative removal. A patient with low perfusion, active bleeding or severe cardiac dysfunction may tolerate neither rapid UF nor large additional fluid shifts.
Suppose a prescription has thirty minutes of isolated UF and three hours of HD. Record each delivered phase and its removal. If the patient has symptomatic hypotension during the first phase, implement the protective protocol and clarify the remaining plan. Continuing merely because the dialysate is off ignores the physiology. The final assessment includes congestion, symptoms and solute adequacy rather than celebrating a reached weight alone.
Convection and Replacement Fluid
Hemofiltration passes plasma water and dissolved solutes across a permeable membrane. The filtration volume may greatly exceed the net fluid removed from the patient, because prescribed sterile replacement fluid restores much of that volume. Hemodiafiltration (HDF) combines this convective process with dialysate diffusion. Small-solute and middle-solute removal depend on membrane properties, effective flows, filtration and dilution.
Replacement before the filter reduces hemoconcentration but dilutes solute concentration at the membrane. Replacement after the filter preserves concentration for removal but increases hemoconcentration within it. The choice affects achievable filtration, clotting and effective clearance. Follow the prescribed replacement location and the device's filtration limits. Monitor pressure trends, clotting, fluid balance and access performance; a displayed total filtration volume is not the patient's net weight loss.
- Technique Main process Nursing distinction
- Ordinary HD Primarily diffusion with net UF Verify bath, flows and net removal
- Isolated UF Pressure-driven water removal Does not replace ordered diffusive clearance
- Hemofiltration Convection with replacement Total filtration differs from net fluid loss
- HDF Diffusion plus convection Replacement-fluid safety and balance are critical
- Hemoperfusion Adsorption to a cartridge Effectiveness and adverse effects depend on substance and cartridge
- Adsorption and Hemoperfusion
Hemoperfusion circulates blood through an adsorptive cartridge, historically charcoal or resin and now other adsorbers for specific purposes. Adsorption binds molecules to a surface instead of requiring them to cross a dialysis membrane. Protein binding or molecular characteristics may make adsorption useful when ordinary dialysis removes an agent poorly, but the actual toxin, distribution volume, exposure timing and cartridge performance determine benefit.
Poison-control and specialist consultation are essential for intoxication. Do not infer that every protein-bound drug is treatable with every cartridge. Cartridge saturation can reduce removal over time; platelets, calcium or medications may also be affected depending on the product. Verify anticoagulation, circuit compatibility, laboratory surveillance and the endpoint. Treatment may be combined with dialysis, but each component has a distinct purpose.
Buffer and Sodium Strategies
Bicarbonate dialysis replaces an important buffer deficit without relying entirely on acetate metabolism. Verify the delivered bicarbonate formulation and total buffer contribution from the acid concentrate. A label setting is not always the entire final buffer exposure. Excess alkalinization can alter ionized calcium, potassium and ventilation. Reassess symptoms and laboratory trends rather than selecting a universally high bicarbonate bath.
A high-sodium bath or sodium profiling may preserve osmolality during treatment and reduce symptoms in selected circumstances, but it can cause positive sodium balance, thirst, larger weight gain and hypertension. It requires an explicit individualized order. Do not automatically raise sodium for every cramp or hypotensive episode. The apparent short-term improvement must be weighed against the next interdialytic interval.
Exam Reasoning
When a question proposes changing modality, ask what problem is being treated: water excess, small-solute burden, middle-solute clearance or a specific poison. Then identify what the method cannot solve. A fluid-overloaded patient with dangerous hyperkalemia still needs a plan for definitive potassium removal; isolated UF alone is inadequate. A patient receiving HDF needs safe substitution fluid and correct balance, not a casual instruction to increase net UF. The nurse verifies the complete order and evaluates both efficacy and tolerance.
Sources: NIDDK hemodialysis , KDIGO AKI guidance .